Invitae Reports Sharp Jump in Q4 Revenues | GenomeWeb

NEW YORK (GenomeWeb) – Invitae reported on Tuesday after the close of the market a nearly 10-fold year-over-year increase in its revenues for the fourth quarter. 

The San Francisco-based cancer genetics testing firm said that it recorded $875,000 in revenues for the three months ended Dec. 31, 2014, compared to $88,000 in the year-ago quarter. More than 1,800 billable reports were delivered during the recently completed quarter, Invitae, which went public last month, said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.